← Leaderboards
Ann B Hill
Oregon Health And Science University
$8,019,118
Attributed
$8,082,258
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $750.2K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$8,082,258 · 8
By mechanism
R01$5,791,536 · 2
R21$1,560,227 · 4
T32$604,215 · 1
R03$126,280 · 1
Top collaborators
- Carrie M Nielson2 shared
Most similar at Oregon Health And Science University
Same institution · by research overlap
- Klaus J Frueh$30,512,644
- Mark K Slifka$36,595,057
- Brent J. Ryckman$3,830,045
- Roger D Cone$16,020,690
- Louis J. Picker$102,909,472
Others in their field
Top investigators on “Cytomegalovirus”
- Constance Ann Benson · University Of California, San Diego$154,530,762
- Curtis L Meinert · Johns Hopkins University$72,267,482
- Louis J. Picker · Oregon Health And Science University$67,787,971
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Dan H. Barouch · Fred Hutchinson Cancer Center$34,316,808
- Jay A Nelson · Oregon Health & Science University$28,085,685
Research focus
CytomegalovirusT-LymphocyteResponseBaseCd8b1 GeneInfectionCytomegalovirus InfectionsImmune ResponseAntigen PresentationCellsDendritic CellsPhenotypeVirusLifeImmune SystemChronicImmuneViralAntigensEconomic InflationMacrophageElderlyChronic DiseaseMemory
Grant awards (30)
Systems biology dissection of the road to T cell exhaustion within the tumor microenvironment to identify novel targets for tumor immunotherapy$162,450
R21 · FY2019 · CA · contact PI
Systems biology dissection of the road to T cell exhaustion within the tumor microenvironment to identify novel targets for tumor immunotherapy$200,970
R21 · FY2018 · CA · contact PI
T cell response to fibroblast-trophic CMV vaccine in humans$192,253
R21 · FY2016 · AI · contact PI
CD8 T Cell Response to Murine Cytomegalovirus$385,000
R01 · FY2015 · AI · contact PI
T cell response to fibroblast-trophic CMV vaccine in humans$257,484
R21 · FY2015 · AI · contact PI
CD8 T Cell Response to Murine Cytomegalovirus$385,000
R01 · FY2014 · AI · contact PI
CD8 T Cell Response to Murine Cytomegalovirus$361,900
R01 · FY2013 · AI · contact PI
Inflammation and T Lymphocyte Immunoregulation$302,139
T32 · FY2013 · AI · contact PI
CD8 T Cell Response to Murine Cytomegalovirus$385,000
R01 · FY2012 · AI · contact PI
Inflammation and T Lymphocyte Immunoregulation$302,076
T32 · FY2012 · AI · contact PI
Cytomegalovirus and diseases of aging: a secondary analysis of NHANES III data$63,140
R03 · FY2012 · AG · contact PI
The CD8 T cell response to murine cytomegalovirus$370,170
R01 · FY2011 · AI · contact PI
Cytomegalovirus and diseases of aging: a secondary analysis of NHANES III data$63,140
R03 · FY2011 · AG · contact PI
The CD8 T cell response to murine cytomegalovirus$373,909
R01 · FY2010 · AI · contact PI
Exploiting the Unique T Cell Response to CMV for a Cancer Vaccine$167,845
R21 · FY2010 · CA · contact PI
The CD8 T cell response to murine cytomegalovirus$377,685
R01 · FY2009 · AI · contact PI
Exploiting the Unique T Cell Response to CMV for a Cancer Vaccine$201,725
R21 · FY2009 · CA · contact PI
The CD8 T cell response to murine cytomegalovirus$377,685
R01 · FY2008 · AI · contact PI
The CD8 T cell response to murine cytomegalovirus$384,271
R01 · FY2007 · AI · contact PI
MECHANISM OF MCMV's INHIBITION OF ANTIGEN PRESENTATION$258,041
R01 · FY2006 · AI · contact PI
IMMUNE CONTROL AND EVASION IN MURINE CMV INFECTION$302,000
R01 · FY2005 · AI
MECHANISM OF MCMV's INHIBITION OF ANTIGEN PRESENTATION$264,250
R01 · FY2005 · AI
IMMUNE CONTROL AND EVASION IN MURINE CMV INFECTION$302,000
R01 · FY2004 · AI
MECHANISM OF MCMV's INHIBITION OF ANTIGEN PRESENTATION$264,250
R01 · FY2004 · AI
IMMUNE CONTROL AND EVASION IN MURINE CMV INFECTION$302,000
R01 · FY2003 · AI
MECHANISM OF MCMV's INHIBITION OF ANTIGEN PRESENTATION$264,250
R01 · FY2003 · AI
IMMUNE CONTROL AND EVASION IN MURINE CMV INFECTION$302,000
R01 · FY2002 · AI
MECHANISM OF MCMV's INHIBITION OF ANTIGEN PRESENTATION$132,125
R01 · FY2002 · AI
INDUCING APOPTOSIS TO AUGMENT CROSS-PRIMING FOR CTL$188,750
R21 · FY2001 · AI
INDUCING APOPTOSIS TO AUGMENT CROSS-PRIMING FOR CTL$188,750
R21 · FY2000 · AI